In conclusion, this study suggested that PF-04447943 ameliorates DSS-induced colitis by prohibiting oxidative stress and inflammation by activating Nrf-2 and modulating NF-kB, STAT3, and inflammasome activity. Here, NFE2L2 is linked to colitis.